Overview of Nrf2 as Therapeutic Target in Epilepsy - Wikidata - thesis-toulmin - TriplyDB

Overview of Nrf2 as Therapeutic Target in Epilepsy

Overview of Nrf2 as Therapeutic Target in Epilepsy

http://www.wikidata.org/entity/Q26799344

about

Testosterone Propionate Exacerbates the Deficits of Nigrostriatal Dopaminergic System and Downregulates Nrf2 Expression in Reserpine-Treated Aged Male Rats Diabetic Wound Healing and Activation of Nrf2 by Herbal Medicine Status epilepticus: Using antioxidant agents as alternative therapies.Computational approaches for innovative antiepileptic drug discovery.Metabolic and Homeostatic Changes in Seizures and Acquired Epilepsy-Mitochondria, Calcium Dynamics and Reactive Oxygen Species.Alleviation of Oxidative Damage and Involvement of Nrf2-ARE Pathway in Mesodopaminergic System and Hippocampus of Status Epilepticus Rats Pretreated by Intranasal Pentoxifylline.Neuroprotective effects of vitamin D alone or in combination with lamotrigine against lithium-pilocarpine model of status epilepticus in rats.Activation of Nrf2 signaling by natural products-can it alleviate diabetes?

P2860

Q33740665-911B92B1-D19A-4532-B3F7-020EEE56A38C Q36199085-8E1423FE-0D64-4C0C-AA3F-F89C478A8428 Q37288222-BC550ACE-DBA5-4FDB-B744-464ADBC5BAFF Q38907478-EB27939F-ACF1-4ED8-BE21-554E5628EF1A Q41660762-CA08FA8E-30C1-453E-BA00-60AE71010EB0 Q41895711-4835CFD4-1FD7-43E0-BB05-9EAEA9CB7E61 Q47979564-A2CC4217-E085-4C9A-90B1-41FA2F164AB1 Q49385295-53CDEC3F-3047-4970-A9B7-0EAAAB565D57

P2860

Overview of Nrf2 as Therapeutic Target in Epilepsy

http://www.wikidata.org/entity/Q26799344

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Overview of Nrf2 as Therapeutic Target in Epilepsy

@ast

Overview of Nrf2 as Therapeutic Target in Epilepsy

@en

Overview of Nrf2 as Therapeutic Target in Epilepsy

@nl

type

label

Overview of Nrf2 as Therapeutic Target in Epilepsy

@ast

Overview of Nrf2 as Therapeutic Target in Epilepsy

@en

Overview of Nrf2 as Therapeutic Target in Epilepsy

@nl

prefLabel

Overview of Nrf2 as Therapeutic Target in Epilepsy

@ast

Overview of Nrf2 as Therapeutic Target in Epilepsy

@en

Overview of Nrf2 as Therapeutic Target in Epilepsy

@nl

P1433

Q26799344-6BE5594E-334D-4935-9BC1-A07A06BBA9A2

P1476

Q26799344-38050F47-083A-4880-96E4-F0227E9F3FE1

P2093

Q26799344-49184867-9A5B-4006-AB39-878550E76B22

Q26799344-58069AA2-6905-4C82-8157-E94B5D03E97C

Q26799344-584DFAFD-45E7-4675-B882-04FC316F7497

Q26799344-61CA029E-548D-496B-BE4D-92DD890B85BE

Q26799344-A6A1AE4A-D012-45EC-8174-8F14C80D1F70

Q26799344-AA7EEBCD-5D3C-48A1-B96D-95837D5CCBC7

Q26799344-AFA13AD5-8432-481C-BD51-1DBD7066FE23

Q26799344-C3CB1F4B-BCAA-4DEF-A7E4-63EA67833DA2

Q26799344-E0057FB1-1461-43E2-8CFF-5E7C4CFCFFC3

Q26799344-EFC0BC81-DCAB-492D-824E-B49E5A8A1059

P275

Q26799344-661C6FAD-BB3F-408A-92BC-24F60FED42C8

P2860

Q26799344-009DDDF8-B9DF-4DC5-BFA2-B10A96FCE922

Q26799344-044E1199-76FE-4772-A2D4-1003A131D858

Q26799344-04E27613-E98F-4269-A3B3-6ADA86B9206F

Q26799344-08E0AF13-D132-40DF-A87E-21B9207C3021

Q26799344-0BB25A5F-2203-4C36-8A73-D12DC9E9EB4F

Q26799344-0C7646DC-0A7A-4F4B-B859-06FE3D280F2F

Q26799344-10D65113-35AD-4DCC-B2E4-48BD622913C9

Q26799344-10F256CD-DB1E-487B-A123-FF3926BAF8BB

Q26799344-12E1A063-8233-4AD4-977F-14CB70ED1F5D

Q26799344-15CE9EC6-8915-4985-9CF3-73229F05989F

P304

Q26799344-BC963C20-332F-4443-9517-0ADBBE2E6CBB

P31

Q26799344-147775D0-DEAD-4AC5-903B-327B4D7D8090

P356

Q26799344-13BC0F30-A431-4B6A-B67D-482F6453A4E5

P407

Q26799344-46BC2EF2-DD60-40CE-852D-C6A3CE7E251D

P433

Q26799344-BE54B5E4-86FB-44F6-93F0-06ED1048D3A3

P478

Q26799344-EE134743-40C6-4054-A5B4-490DF70A9EB2

P50

Q26799344-6D3BE2EB-C1EF-4637-AD84-074B3F5BE6C2

P5008

Q26799344-C9C0F340-DE86-4D03-A805-7FB40DD955AC

P577

Q26799344-1B3C88EC-021C-4886-A34C-75E7363CD7B9

P5875

Q26799344-91E08280-EC2A-4C3B-B23E-C085FF224DFA

P698

Q26799344-6C862C3C-55AC-48E4-A988-EF44A8501B26

P921

Q26799344-02F808D4-DD90-45AC-8725-851E4B15A08B

Q26799344-312F4243-D0D8-4093-899B-9AE0BBFC36D3

Q26799344-C0FF02A2-3A85-406E-AF9E-B59463B479C4

Q26799344-C3CAB616-1925-4862-9F98-D9F729FB3CE9

Q26799344-FA362A92-A6E4-4EED-A984-309B278C05BD

P932

Q26799344-6CD4D7DA-5EBB-434A-B68C-87C920C694BA

P356

P1433

International Journal of Molecular Sciences

P1476

Overview of Nrf2 as Therapeutic Target in Epilepsy

@en

P2093

Aristides Sampieri

http://www.w3.org/2001/XMLSchema#string

Cecilia Zavala-Tecuapetla

http://www.w3.org/2001/XMLSchema#string

Claudia Pérez-Cruz

http://www.w3.org/2001/XMLSchema#string

Elvia Coballase-Urrutia

http://www.w3.org/2001/XMLSchema#string

Hortencia Montesinos-Correa

http://www.w3.org/2001/XMLSchema#string

Jacqueline Hernández-Damián

http://www.w3.org/2001/XMLSchema#string

José Pedraza-Chaverri

http://www.w3.org/2001/XMLSchema#string

Leticia Granados-Rojas

http://www.w3.org/2001/XMLSchema#string

Liliana Carmona-Aparicio

http://www.w3.org/2001/XMLSchema#string

Liliana Rivera-Espinosa

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation

DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2

Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex.

Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region

Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2

Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain

Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene

Modulation of oxidative stress and mitochondrial function by the ketogenic diet

Relevance of the glutathione system in temporal lobe epilepsy: evidence in human and experimental models

Mitochondrial involvement and oxidative stress in temporal lobe epilepsy

P304

18348-18367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJMS160818348

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Noemí Cárdenas-Rodríguez

P5008

P577

2015-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281814881

http://www.w3.org/2001/XMLSchema#string

P698

26262608

http://www.w3.org/2001/XMLSchema#string

P921

Aagianik kimischri

DNA-binding protein

transcription factor

P932

4581249

http://www.w3.org/2001/XMLSchema#string